|
|
(Transportation-News.com, October 04, 2017 ) According to Publisher, the Global Apheresis Equipment market is accounted for $1.42 billion in 2016 and is expected to reach $3.37 billion by 2022 growing at a CAGR of 15.4% from 2016 to 2022. Increasing incidence of cardiovascular disorders, demand for automated blood component separation procedures, adoption of technologically advanced automated products, government focusing on healthcare infrastructure and rise in the number of platelet donors are fueling the market growth. However, histocompatibility issues, high cost of equipment and lack of trained technicians will hamper market growth.
For more information about this report: http://www.reportsweb.com/apheresis-equipment-global-market-outlook-2016-2022
Plasmapheresis segment accounted for the largest market share of the apheresis procedure market due to growing incidence of hematological disorders. Apheresis disposable kits is the largest segment in the total apheresis equipment product market as single use products are in high demand along with high usage volume. Neurology segment is projected to witness the fastest growth under application as individuals are affected with multiple sclerosis. North America is the leading market because of the presence of sophisticated healthcare infrastructure. Asia Pacific is anticipated to be the fastest growing market due to Increasing prevalence of blood disorders and plasma products in China, Japan, Australia, Korea and India.
Some of the key players in global Apheresis Equipment market are Asahi Kasei Kuraray Medical Co., Ltd., Fenwal, Inc., Braun Melsungen AG, Cerus Corporation, Fresenius Se & Co. KGAA, Medica SpA, Kaneka Corporation, Nikkiso Co., Ltd, Kawasumi Laboratories Inc, Therakos, Inc., HemaCare Corporation, Haemonetics Corporation and Terumo BCT, Inc.
Technologies Covered:
-Membrane Filtration
-Centrifugation
-Continuous Flow
-Intermittent Flow
Procedures Covered:
-Erythrocytapheresis
-Extracorporeal Immunoadsorption (ECI)
-Leukapheresis
-Plasmapheresis
-Photopheresis
-Low Density Lipoprotein (LDL) Apheresis
-Plateletpheresis
-Therapeutic CytApheresis Equipment
-Other Procedures
-Lipidpheresis
-Lymphapheresis
Request Sample Copy at http://www.reportsweb.com/inquiry&RW0001716578/sample
Applications Covered:
-Hematology
-Neurological Disorders
-Renal Disorders
-Metabolic Disorders
-Autoimmune Disorders
-Cardiovascular Disorders
-Other Applications
Products Covered:
-Apheresis Machine
-Disposable Apheresis kits
Regions Covered:
-North America
-US
-Canada
-Mexico
-Europe
-Germany
-France
-Italy
-UK
-Spain
-Rest of Europe
-Asia Pacific
-Japan
-China
-India
-Australia
-New Zealand
-Rest of Asia Pacific
-Rest of the World
-Middle East
-Brazil
-Argentina
-South Africa
-Egypt
Company Profiling
11.1 Asahi Kasei Kuraray Medical Co., Ltd.
11.2 Fenwal, Inc.
11.3 B Braun Melsungen AG
11.4 Cerus Corporation
11.5 Fresenius Se & Co. KGAA
11.6 Medica SpA
11.7 Kaneka Corporation
11.8 Nikkiso Co., Ltd
11.9 Kawasumi Laboratories Inc
11.10 Therakos, Inc.
11.11 HemaCare Corporation
11.12 Haemonetics Corporation
11.13 Terumo BCT, Inc.
Inquire before Buying at http://www.reportsweb.com/inquiry&RW0001716578/buying
ReportsWeb.com
Rajat Sahni
+1-646-491-9876
sales@reportsweb.com
Source: EmailWire.Com 
Source: EmailWire.com
|
